English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
7 天
on MSN
I was diagnosed with stage 3 colon cancer at 44 — the 5 symptoms I ignored
In 2012, at the age of 44, was diagnosed with stage 3c colon cancer. Since then, she has been an advocate for awareness on TikTok.
5 天
on MSN
Colon cancer Stage 3 survivor diagnosed at 44 shares early symptoms that can help
Colon cancer, particularly prevalent in people over 50, starts as benign polyps and can progress if undetected. Cheryl, a ...
6 天
on MSN
Woman Diagnosed With Stage 3 Colon Cancer at 44; 5 Critical Symptoms She Ignored
A 44-year-old woman who survived stage 3 colon cancer after ignoring the signs for years is now warning others about one of ...
The American Journal of Managed Care
1 天
Ethnic Disparities Identified in Colorectal Cancer Diagnoses, Study Finds
New research examines how ethnicity impacts colorectal cancer diagnosis, early-onset colorectal cancer (CRC) prevalence, and ...
2 天
‘Don’t be like me’: Bowel cancer signs woman wished she hadn’t ignored
A bowel cancer survivor has shared the five signs and symptoms she ignored before being diagnosed with the life-threatening disease.
6 天
How a liver transplant helped one woman with bowel cancer become disease free
Still, Perea is not the first case of a liver transplant successfully curing bowel cancer in a patient. The body of evidence ...
12 天
Insurance must now cover all parts of Nebraskans’ colorectal cancer screenings
New law expands coverage to polyp removal, preparation medications, anesthesia and other ‘integral’ parts of colonoscopies ...
devdiscourse
11 天
How Lifestyle and Screening Shape Colorectal Cancer Risks Across Generations
A RAND Corporation study analyzed colorectal cancer trends in the U.S. from 1978 to 2017, revealing declining rates in older ...
Pharmaceutical Technology
9 天
PF-07826390 by Pfizer for Colorectal Cancer: Likelihood of Approval
PF-07826390 is under development for the treatment of solid tumors including non-small cell lung cancer, colorectal cancer and renal cell carcinoma. It acts by targeting leukocyte immunoglobulin like ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈